ES2052685T3 - Metodo para producir un adyuvante libre. - Google Patents

Metodo para producir un adyuvante libre.

Info

Publication number
ES2052685T3
ES2052685T3 ES88200443T ES88200443T ES2052685T3 ES 2052685 T3 ES2052685 T3 ES 2052685T3 ES 88200443 T ES88200443 T ES 88200443T ES 88200443 T ES88200443 T ES 88200443T ES 2052685 T3 ES2052685 T3 ES 2052685T3
Authority
ES
Spain
Prior art keywords
produce
free adjuvant
adjuvant
vaccines
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88200443T
Other languages
English (en)
Inventor
Eric Onno Rijke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2052685T3 publication Critical patent/ES2052685T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

DE ACUERDO CON LA PRESENTE INVENCION SE PROPORCIONAN VACUNAS AXENTAS DE ACEITE QUE CONTIENEN POLIOXIPROPILEN-POLIOXIETILEN GLICOLES ASI COMO UN POLIMERO DE ACIDO ACRILICO, COMO COADYUVANTE. ESTAS VACUNAS MUESTRAN EXCELENTES PROPIEDADES INMUNIZANTES
ES88200443T 1987-03-17 1988-03-09 Metodo para producir un adyuvante libre. Expired - Lifetime ES2052685T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700629 1987-03-17

Publications (1)

Publication Number Publication Date
ES2052685T3 true ES2052685T3 (es) 1994-07-16

Family

ID=19849718

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88200443T Expired - Lifetime ES2052685T3 (es) 1987-03-17 1988-03-09 Metodo para producir un adyuvante libre.

Country Status (9)

Country Link
US (1) US5026543A (es)
EP (1) EP0283085B1 (es)
JP (1) JP2562827B2 (es)
DE (1) DE3875762T2 (es)
DK (1) DK167849B1 (es)
ES (1) ES2052685T3 (es)
GR (1) GR3007039T3 (es)
HU (1) HU202119B (es)
ZA (1) ZA881694B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
EP0688205A1 (en) * 1993-03-11 1995-12-27 Secretech, Inc. Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
WO1995011700A1 (en) * 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5891393A (en) * 1996-04-09 1999-04-06 The University Of North Carolina At Chapel Hill Method for the microbial decontamination of blood platelets
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
NZ514323A (en) * 1999-03-24 2003-03-28 Secr Defence A immunostimulant containing an acitive agent and an adjuvant which increases the effect of the active agent
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
ES2391770T3 (es) 2003-01-21 2012-11-29 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos de triptantrina para la potenciación inmune
US7893096B2 (en) 2003-03-28 2011-02-22 Novartis Vaccines And Diagnostics, Inc. Use of small molecule compounds for immunopotentiation
JP2008504292A (ja) 2004-06-24 2008-02-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 免疫増強用の化合物
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8097245B2 (en) 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DK3766518T3 (da) 2005-12-29 2026-04-13 Boehringer Ingelheim Animal Health Usa Inc Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
EP3868400A1 (en) 2005-12-29 2021-08-25 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
WO2007109810A2 (en) * 2006-03-23 2007-09-27 Novartis Ag Methods for the preparation of imidazole-containing compounds
CA2646891A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
ES2588183T3 (es) * 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
WO2010138522A2 (en) 2009-05-26 2010-12-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
CA2866170A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
US12558395B2 (en) 2015-07-29 2026-02-24 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6889699B2 (ja) 2015-07-29 2021-06-18 アドバンスド バイオニュートリション コープ． 特定栄養用途のための安定乾燥プロバイオティクス組成物
TW202015725A (zh) 2018-06-04 2020-05-01 美商亞博創新醫藥有限公司 Tlr7 肽結合物
KR20210027381A (ko) 2018-07-02 2021-03-10 아유비스 리서치, 인코포레이티드 신규 면역조절 소분자

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178350A (en) * 1961-05-15 1965-04-13 Cutler Lab Inc Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3869546A (en) * 1972-12-22 1975-03-04 Cutter Lab Adjuvant compositions and medicinal mixtures comprising them
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants

Also Published As

Publication number Publication date
ZA881694B (en) 1988-09-06
HUT47224A (en) 1989-02-28
JP2562827B2 (ja) 1996-12-11
DK141488D0 (da) 1988-03-15
DE3875762D1 (de) 1992-12-17
DE3875762T2 (de) 1993-05-13
DK141488A (da) 1988-09-18
EP0283085B1 (en) 1992-11-11
DK167849B1 (da) 1993-12-27
JPS63253032A (ja) 1988-10-20
HU202119B (en) 1991-02-28
US5026543A (en) 1991-06-25
EP0283085A1 (en) 1988-09-21
GR3007039T3 (es) 1993-07-30

Similar Documents

Publication Publication Date Title
ES2052685T3 (es) Metodo para producir un adyuvante libre.
ES2080227T3 (es) Terpolimerizados del etileno, su fabricacion y el empleo de los mismos como aditivos para los destilados de aceite mineral.
ES2081411T3 (es) Procedimiento para la obtencion de poliisobuteno.
ATE42776T1 (de) Acrylfasern zur herstellung von kohlenstoffasern.
ES2046996T3 (es) Procedimiento para purificar organofosfitos terciarios.
BR8303580A (pt) Processo para inibir a mineralizacao de tecido natural fixado, bem como processo para inibir a calcinacao de tal tecido
GEP19960642B (en) Method of acylated diketonic compounds preparation
KR840008651A (ko) 퓨로-(3,4-c)-피리딘 유도체의 제조방법
BR8604130A (pt) Processo para a obtencao de um polimero por blocos,bem como utilizacao de tal polimero
ES521895A0 (es) Procedimiento de preparacion de benzoazacicloalquil-espiroimidazolidina, asi como de sus sales obtenidas con bases minerales u organicas farmaceuticamente aceptables.
MX9302076A (es) Proceso novedoso para preparar derivados de piperidina.
ES539963A0 (es) Un metodo para preparar un articulo conformado a partir de conposiciones fluoroelastomeras que contienen sulfonamidas fluoroalifaticas en calidad de agentes de curado.
PT88328A (pt) Processo para a preparacao de composicoes polimericas que endurecem por accao da agua contendo, como aditivos, modificadores polimericos do tipo polieterpolissiloxano-poliuretano
ES2053950T3 (es) Vacuna contra la coccidiosis.
ES521636A0 (es) Procedimiento de fabricacion de monoeter de monoetilenglicol.
IE44868L (en) Improving flammability retardancy
ES2083653T3 (es) Carbamatos, procedimiento para su obtencion, asi como combustibles y lubricantes que contienen los carbamatos.
ES2033273T3 (es) Procedimiento para la obtencion de terpolimeros.
ES523963A0 (es) Metodo para la fabricazcion de velos de fibras prendidos con alfileres, de fibras minerales, en especial refractarias.
ES541611A0 (es) Un procedimiento para preparar alquilen-glicoles
ES2131137T3 (es) Procedimiento para producir cromanos.
GT198304141A (es) Procedimiento para la preparacion de esteres de cianometilo opticamente activos.
ES2059711T3 (es) Metodo para la preparacion de una secuencia de acido nucleico codificante de un polipeptido de eimeria tenella.
ES2058269T3 (es) Di-t-butilfenil-alquil y -bencil-eteres.
GB1110600A (en) Method of making phosphorus-containing diols

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 283085

Country of ref document: ES